Patients Preference for Oral or i.v. Therapy
NCT00212589
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Capecitabine
DRUG:
Fluorouracil + folinic acid
Sponsor
Odense University Hospital